glp-1 and alcohol medications: The next big thing in use disorder treatment? – Recovery Research Institute GLP-1s Hold Promise as Treatment

Start your weight loss today with coaching, a metabolic test and medication at an affordable price.

The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031

Meals are high in protein to help preserve lean muscle, portion-controlled to match your reduced appetite, and made with whole ingredients that are easier on your stomach

These easy-to-use transdermal patches deliver a blend of plant-based ingredients including berberine and cinnamon extract through a convenient, mess-free application

Demand for these drugs has increased rapidly in recent years, as indications have expanded, but they remain expensive